About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05643456

Surgery for Large Angle Exotropia Two Muscles Versus Three Muscles

Comparison Between The Results Of Two Muscles Surgery And Three Muscles Surgery For The Treatment Of Large Angle Exotropia

Lead sponsor: Cairo University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Cairo University

Exotropia is classified as Primary which includes constant and intermittent exotropias. Secondary XT include Sensory and consecutive XT. Management for IXT consists of non-surgical and surgical treatment. There is some controversy regarding the optimal surgical method varying between bilateral lateral rectus recession (BLR), unilateral lateral rectus recession-medial rectus resection (RR) and bilateral medial rectus resection (BMR).

Age

5 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients above age of 5 years with concomitant Exotropia of (40-55) PD of any type.

Exclusion Criteria

•1. Angle of deviation less than 40 PD or more than 55 PD.
•2. History of previous surgery.
•3. Inconcomitant exotropia.
•4. Incomitance in any gaze.
•5. Associated vertical deviation(oblique dysfunction,A or V pattern).
•6. Patients with neurological deficit.

Related studies

Comparative Study of Muscle Transplantation Versus Y Splitting Recession Technique in Treatment of Large Angle Exotropia

NCT07350330 · Exotropia

Using Dichoptic Therapy to Treat Intermittent Exotropia

NCT06529016 · Exotropia Intermittent

Active Not RecruitingNA

Bilateral Lateral Rectus Recession Versus Bilateral Primary Medial Rectus Resection in Intermittent Exotropia

NCT06650735 · Intermittent Exotropia

Evaluation of Exotropia After Patching the Eye or After Prism Adaptation

NCT05242510 · Exotropia

Symmetric vs Asymmetric BLR Recession in Management of Basic IXT With Ocular Dominance

NCT05234957 · Intermittent Exotropia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment69

Start dateJul 2020

Last updatedDec 8, 2022

Condition

Locations shown

Reham fawzy elsherbiny

Giza

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions